Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Methods and analysis A randomised, multicenter pragmatic clinical trial with three parallel groups consisting of primary healthcare patients suffering from subclinical, mild or moderate depression.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

People need more and better treatment options for asymptomatic SARS-CoV-2 infection (the virus that causes COVID-19) or mild, moderate, or severe COVID-19. We wanted to know if inhaled corticosteroids ...

Kolkata: The number of Covid patients admitted due to their comorbidities rather than the virus has been increasing at ...

Introduction ‘One-off’ systematic case-finding for COPD using a respiratory screening questionnaire is more effective and cost-effective than routine care at identifying new cases. However, it is not ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

The work reveals that nearly one-third of COPD patients may be using inhalers that are not optimally suited to their breathing capabilities, potentially compromising treatment effectiveness. COPD is a ...